Green AK, Zhou Q, Iasonos A, Zammarrelli WA, et al. A Phase II Study of Fulvestrant plus Abemaciclib in Hormone Receptor-Positive Advanced or Recurrent Endometrial Cancer. Clin Cancer Res 2024 Nov 19. doi: 10.1158/1078-0432.CCR-24-1999.
PMID: 39561275